Aspira Women's Health Inc.
AWHL· OTC
Released May 14, 2020, after the close
10-Q filed May 14, 2020, 44 days after period end · 0000926617-20-000037
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $1.22M | $803.00K | $649.00K | $726.00K |
| Net Income | -$3.71M | -$3.72M | -$2.85M | -$2.67M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.04 |
| -$0.05 |
| -$0.05 |
| -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.